+ Open data
Open data
- Basic information
Basic information
| Entry | Database: PDB / ID: 6god | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | KRAS full length wild-type GPPNHP | ||||||||||||
|  Components | GTPase KRas | ||||||||||||
|  Keywords | ONCOPROTEIN / KRAS full lenght | ||||||||||||
| Function / homology |  Function and homology information response to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation ...response to mineralocorticoid / GMP binding / forebrain astrocyte development / LRR domain binding / regulation of synaptic transmission, GABAergic / negative regulation of epithelial cell differentiation / response to isolation stress / response to gravity / epithelial tube branching involved in lung morphogenesis / type I pneumocyte differentiation / Rac protein signal transduction / positive regulation of Rac protein signal transduction / Signaling by RAS GAP mutants / Signaling by RAS GTPase mutants / Activation of RAS in B cells / myoblast proliferation / skeletal muscle cell differentiation / RAS signaling downstream of NF1 loss-of-function variants / RUNX3 regulates p14-ARF / positive regulation of glial cell proliferation / SOS-mediated signalling / Activated NTRK3 signals through RAS / Activated NTRK2 signals through RAS / SHC1 events in ERBB4 signaling / cardiac muscle cell proliferation / Signalling to RAS / Activated NTRK2 signals through FRS2 and FRS3 / SHC-related events triggered by IGF1R / Estrogen-stimulated signaling through PRKCZ / glial cell proliferation / SHC-mediated cascade:FGFR3 / MET activates RAS signaling / SHC-mediated cascade:FGFR2 / PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases / Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants / Signaling by PDGFRA extracellular domain mutants / SHC-mediated cascade:FGFR4 / Erythropoietin activates RAS / SHC-mediated cascade:FGFR1 / Signaling by FGFR4 in disease / Signaling by CSF3 (G-CSF) / FRS-mediated FGFR3 signaling / Signaling by FLT3 ITD and TKD mutants / FRS-mediated FGFR2 signaling / FRS-mediated FGFR4 signaling / p38MAPK events / FRS-mediated FGFR1 signaling / Signaling by FGFR3 in disease / protein-membrane adaptor activity / Tie2 Signaling / striated muscle cell differentiation / Signaling by FGFR2 in disease / GRB2 events in EGFR signaling / SHC1 events in EGFR signaling / Signaling by FLT3 fusion proteins / FLT3 Signaling / Signaling by FGFR1 in disease / EGFR Transactivation by Gastrin / NCAM signaling for neurite out-growth / homeostasis of number of cells within a tissue / CD209 (DC-SIGN) signaling / GRB2 events in ERBB2 signaling / Downstream signal transduction / Insulin receptor signalling cascade / Ras activation upon Ca2+ influx through NMDA receptor / SHC1 events in ERBB2 signaling / response to glucocorticoid / Constitutive Signaling by Overexpressed ERBB2 / Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants / VEGFR2 mediated cell proliferation / small monomeric GTPase / FCERI mediated MAPK activation / liver development / RAF activation / Signaling by ERBB2 TMD/JMD mutants / female pregnancy / Signaling by SCF-KIT / Signaling by high-kinase activity BRAF mutants / Constitutive Signaling by EGFRvIII / regulation of long-term neuronal synaptic plasticity / MAP2K and MAPK activation / Signaling by ERBB2 ECD mutants / Signaling by ERBB2 KD Mutants / visual learning / cytoplasmic side of plasma membrane / cytokine-mediated signaling pathway / Regulation of RAS by GAPs / Signaling by CSF1 (M-CSF) in myeloid cells / RAS processing / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / GDP binding / Signaling by BRAF and RAF1 fusions / positive regulation of cellular senescence / DAP12 signaling / MAPK cascade / Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants Similarity search - Function | ||||||||||||
| Biological species |  Homo sapiens (human) | ||||||||||||
| Method |  X-RAY DIFFRACTION /  SYNCHROTRON /  MOLECULAR REPLACEMENT / Resolution: 1.71 Å | ||||||||||||
|  Authors | Cruz-Migoni, A. / Quevedo, C.E. / Carr, S.B. / Ehebauer, M.T. / Phillips, S.V.E. / Rabbitts, T.H. | ||||||||||||
| Funding support |  United Kingdom, 3items 
 | ||||||||||||
|  Citation |  Journal: Proc. Natl. Acad. Sci. U.S.A. / Year: 2019 Title: Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. Authors: Cruz-Migoni, A. / Canning, P. / Quevedo, C.E. / Bataille, C.J.R. / Bery, N. / Miller, A. / Russell, A.J. / Phillips, S.E.V. / Carr, S.B. / Rabbitts, T.H. | ||||||||||||
| History | 
 | 
- Structure visualization
Structure visualization
| Structure viewer | Molecule:  Molmil  Jmol/JSmol | 
|---|
- Downloads & links
Downloads & links
- Download
Download
| PDBx/mmCIF format |  6god.cif.gz | 54.2 KB | Display |  PDBx/mmCIF format | 
|---|---|---|---|---|
| PDB format |  pdb6god.ent.gz | 37.5 KB | Display |  PDB format | 
| PDBx/mmJSON format |  6god.json.gz | Tree view |  PDBx/mmJSON format | |
| Others |  Other downloads | 
-Validation report
| Summary document |  6god_validation.pdf.gz | 779.5 KB | Display |  wwPDB validaton report | 
|---|---|---|---|---|
| Full document |  6god_full_validation.pdf.gz | 780.5 KB | Display | |
| Data in XML |  6god_validation.xml.gz | 10.3 KB | Display | |
| Data in CIF |  6god_validation.cif.gz | 13.6 KB | Display | |
| Arichive directory |  https://data.pdbj.org/pub/pdb/validation_reports/go/6god  ftp://data.pdbj.org/pub/pdb/validation_reports/go/6god | HTTPS FTP | 
-Related structure data
| Related structure data |  6goeC  6gofC  6gogC  6gomC  6gqtC  6gqwC  6gqxC  6gqyC  4dstS S: Starting model for refinement C: citing same article ( | 
|---|---|
| Similar structure data | 
- Links
Links
- Assembly
Assembly
| Deposited unit |  
 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 
 | ||||||||
| Unit cell | 
 | ||||||||
| Components on special symmetry positions | 
 | 
- Components
Components
| #1: Protein | Mass: 19575.094 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.)  Homo sapiens (human) / Gene: KRAS, KRAS2, RASK2 / Production host:   Escherichia coli (E. coli) / References: UniProt: P01116 | ||||||
|---|---|---|---|---|---|---|---|
| #2: Chemical | | #3: Chemical | ChemComp-GNP / | #4: Chemical | ChemComp-GOL / | #5: Water | ChemComp-HOH / |  | 
-Experimental details
-Experiment
| Experiment | Method:  X-RAY DIFFRACTION / Number of used crystals: 1 | 
|---|
- Sample preparation
Sample preparation
| Crystal | Density Matthews: 2.35 Å3/Da / Density % sol: 47.74 % | 
|---|---|
| Crystal grow | Temperature: 277 K / Method: vapor diffusion, sitting drop / pH: 8 / Details: 0.1 M TrisCl, 0.2 M NaOAc and 30-35 % PEG 4000 | 
-Data collection
| Diffraction | Mean temperature: 100 K | 
|---|---|
| Diffraction source | Source:  SYNCHROTRON / Site:  ESRF  / Beamline: MASSIF-1 / Wavelength: 0.966 Å | 
| Detector | Type: DECTRIS PILATUS3 2M / Detector: PIXEL / Date: Apr 10, 2017 | 
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray | 
| Radiation wavelength | Wavelength: 0.966 Å / Relative weight: 1 | 
| Reflection | Resolution: 1.7→51.11 Å / Num. obs: 18963 / % possible obs: 98 % / Redundancy: 3 % / Rmerge(I) obs: 0.051 / Rrim(I) all: 0.062 / Net I/σ(I): 11.1 | 
| Reflection shell | Resolution: 1.7→1.73 Å / Redundancy: 3.2 % / Rmerge(I) obs: 0.468 / Mean I/σ(I) obs: 2.3 / CC1/2: 0.56 / Rrim(I) all: 0.566 / % possible all: 99.6 | 
- Processing
Processing
| Software | 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure:  MOLECULAR REPLACEMENT Starting model: 4DST Resolution: 1.71→51.11 Å / Cor.coef. Fo:Fc: 0.963 / Cor.coef. Fo:Fc free: 0.936 / SU B: 2.738 / SU ML: 0.09 / Cross valid method: THROUGHOUT / ESU R: 0.114 / ESU R Free: 0.117 / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso  mean: 32.916 Å2 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: 1  / Resolution: 1.71→51.11 Å 
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refine LS restraints | 
 | 
 Movie
Movie Controller
Controller













 PDBj
PDBj





















